Cost-minimization analysis (FINAL)

cost minimization analysis (CMA)

A pharmacoeconomic tool for comparing all of the relevant costs and outcomes (consequences) of two or more therapeutic interventions

objective of CMA

to choose the least costly alternative among interventions with equivalent outcomes

full

CMA is a _______ pharmacoeconomic analysis.

orange book

includes approved drug products with therapeutic equivalence evaluations (current through April 2025)

meta-analysis

a method for systematically combining pertinent qualitative and quantitative study data from several selected studies to develop a single conclusion that has greater statistical power

time-motion analysis

A standard analytic procedure for determining the time and energy spent in activities over a period of time (Gross, 1984)